David A. Siegel Inogen Inc Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Inogen Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 86,300 shares of INGN stock, worth $772,384. This represents 0.0% of its overall portfolio holdings.

Number of Shares

86,300

Previous 147,600 41.53%

Holding current value

$772,384

Previous $1.2 Million 30.19%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.67 - $12.98 $470,171 - $795,674	-61,300 Reduced 41.53%	86,300 $837,000
Q2 2024 Aug 14, 2024	SELL	$6.3 - $8.95 $552,510 - $784,914	-87,700 Reduced 37.27%	147,600 $1.2 Million
Q1 2024 May 15, 2024	SELL	$5.26 - $10.15 $269,312 - $519,680	-51,200 Reduced 17.87%	235,300 $1.9 Million
Q4 2023 Feb 14, 2024	BUY	$4.21 - $6.32 $661,391 - $992,872	157,100 Added 121.41%	286,500 $1.57 Million
Q3 2023 Nov 14, 2023	BUY	$5.14 - $11.28 $73,291 - $160,841	14,259 Added 12.38%	129,400 $675,000
Q2 2023 Aug 14, 2023	BUY	$10.01 - $13.86 $367,777 - $509,230	36,741 Added 46.86%	115,141 $1.33 Million
Q1 2023 May 15, 2023	BUY	$11.88 - $26.0 $666,468 - $1.46 Million	56,100 Added 251.57%	78,400 $978,000
Q4 2022 Feb 14, 2023	BUY	$19.14 - $24.55 $51,678 - $66,285	2,700 Added 13.78%	22,300 $439,000
Q3 2022 Nov 14, 2022	SELL	$22.74 - $31.8 $131,892 - $184,440	-5,800 Reduced 22.83%	19,600 $476,000
Q2 2022 Aug 15, 2022	SELL	$22.88 - $35.28 $148,720 - $229,320	-6,500 Reduced 20.38%	25,400 $614,000
Q1 2022 May 16, 2022	SELL	$28.1 - $35.25 $460,840 - $578,100	-16,400 Reduced 33.95%	31,900 $1.03 Million
Q4 2021 Feb 14, 2022	BUY	$29.66 - $44.0 $670,316 - $994,400	22,600 Added 87.94%	48,300 $1.64 Million
Q3 2021 Nov 15, 2021	SELL	$43.09 - $82.26 $1.57 Million - $3 Million	-36,500 Reduced 58.68%	25,700 $1.11 Million
Q2 2021 Aug 16, 2021	SELL	$52.03 - $68.77 $3.25 Million - $4.3 Million	-62,500 Reduced 50.12%	62,200 $4.05 Million
Q1 2021 May 17, 2021	SELL	$43.96 - $55.99 $1.16 Million - $1.48 Million	-26,400 Reduced 17.47%	124,700 $6.55 Million
Q4 2020 Feb 16, 2021	SELL	$27.19 - $44.68 $2.59 Million - $4.26 Million	-95,400 Reduced 38.7%	151,100 $6.75 Million
Q3 2020 Nov 16, 2020	SELL	$27.01 - $37.31 $861,619 - $1.19 Million	-31,900 Reduced 11.46%	246,500 $7.15 Million
Q2 2020 Aug 14, 2020	SELL	$32.85 - $53.77 $725,985 - $1.19 Million	-22,100 Reduced 7.35%	278,400 $9.89 Million
Q1 2020 May 15, 2020	SELL	$32.63 - $67.59 $871,221 - $1.8 Million	-26,700 Reduced 8.16%	300,500 $15.5 Million
Q4 2019 Feb 14, 2020	SELL	$45.95 - $76.15 $1.01 Million - $1.67 Million	-21,900 Reduced 6.27%	327,200 $22.4 Million
Q3 2019 Nov 14, 2019	BUY	$41.82 - $66.71 $815,490 - $1.3 Million	19,500 Added 5.92%	349,100 $16.7 Million
Q2 2019 Aug 14, 2019	BUY	$63.19 - $95.15 $10.1 Million - $15.2 Million	159,800 Added 94.11%	329,600 $22 Million
Q1 2019 May 15, 2019	BUY	$90.12 - $152.23 $8.76 Million - $14.8 Million	97,200 Added 133.88%	169,800 $16.2 Million
Q4 2018 Feb 14, 2019	BUY	$112.83 - $239.74 $3.66 Million - $7.77 Million	32,400 Added 80.6%	72,600 $9.02 Million
Q3 2018 Nov 14, 2018	SELL	$189.1 - $282.92 $453,840 - $679,008	-2,400 Reduced 5.63%	40,200 $9.81 Million
Q2 2018 Aug 14, 2018	BUY	$123.8 - $192.48 $2.67 Million - $4.16 Million	21,600 Added 102.86%	42,600 $7.94 Million
Q1 2018 May 15, 2018	BUY	$114.22 - $133.22 $274,128 - $319,728	2,400 Added 12.9%	21,000 $2.58 Million
Q4 2017 Feb 14, 2018	SELL	$93.4 - $128.74 $607,100 - $836,810	-6,500 Reduced 25.9%	18,600 $2.22 Million
Q3 2017 Nov 14, 2017	BUY	$91.08 - $104.49 $2.29 Million - $2.62 Million	25,100	25,100 $2.39 Million

Others Institutions Holding INGN

# of Institutions

143

Shares Held

21M

Call Options Held

119K

Put Options Held

149K

View Full List

About Inogen Inc

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $205M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

More about INGN

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account